In a surprising move, just minutes before President Donald Trump was officially sworn in for his second term, FBI Director Paul Abbate announced his retirement. The timing of his departure, coinciding with the beginning of a new administration, raised eyebrows, particularly given the ongoing scrutiny surrounding the FBI’s actions during the last eight years. Abbate, who had served as deputy director before taking the helm, left behind a bureau at the center of political controversy, leaving many to wonder about the potential implications for the agency under the incoming administration.
Abbate, a longtime deputy director for the FBI, was expected to temporarily step in as acting FBI director during the transition under the new Trump administration. However, he unexpectedly announced his retirement. He made the surprise revelation in an internal email to senior officials on Monday, just ahead of Trump’s inauguration.
“When the director asked me to stay on past my mandatory date for a brief time, I did so to help ensure continuity and the best transition for the F.B.I. Now, with new leadership inbound, after nearly four years in the deputy role, I am departing the F.B.I.,” Abbate wrote in the email. “I have complete confidence in you and in your ability as a team to continue to carry out our mission of protecting the American people and upholding the Constitution.”
Abbate, who was with the FBI for 28 years, had only been in charge of the agency for one day after former FBI Director Christopher Wray announced that he would resign on December 11. His resignation went into effect Sunday. It is not clear who will replace Abbate as acting FBI Director. However, the White House issued a list of potential leaders, saying that Brian Driscoll would serve as head of the FBI until the position was filled. […]
— Read More: townhall.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
